The transcriptional repressor HDAC7 promotes apoptosis and c-Myc downregulation in particular types of leukemia and lymphoma

Cell Death and Disease

Volumn 6, Issue 2, 2015, Pages

  Barneda Zahonero, B ^a   Collazo, O ^a   Azagra, A ^a   Fernandez Duran I ^a   Serra Musach, J ^a   Islam, A B M M K ^b   Vega Garcia N ^c   Malatesta, R ^c   Camos M ^c   Gomez A ^a   Roman Gonzalez L ^a   Vidal, A ^d   Lopez Bigas N ^e,f   Villanueva, A ^a   Esteller, M ^a,f,g   Parra, M ^a  

^a BELLVITGE BIOMEDICAL RESEARCH INSTITUTE IDIBELL   (Spain)

^b UNIVERSITY OF DHAKA   (Bangladesh)

^c HOSPITAL SANT JOAN DE DÉU   (Spain)

^d HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^e UNIVERSITAT POMPEU FABRA   (Spain)

^f INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

^g UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

B CELL MATURATION ANTIGEN; HISTONE DEACETYLASE 3; HISTONE DEACETYLASE 7; MYOCYTE ENHANCER FACTOR 2; SILENCING MEDIATOR OF RETINOID AND THYROID HORMONE RECEPTOR; HISTONE DEACETYLASE; MYC PROTEIN; PROTEIN BINDING;

ACUTE LYMPHOBLASTIC LEUKEMIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; B LYMPHOCYTE; BURKITT LYMPHOMA; CANCER INHIBITION; CELL VIABILITY; LEUKEMOGENESIS; MOUSE; NONHUMAN; ONCOGENE C MYC; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RECEPTOR DOWN REGULATION; TRANSCRIPTION REGULATION; TUMOR XENOGRAFT; ANIMAL; CELL CYCLE; CELL NUCLEUS; CELL REPROGRAMMING TECHNIQUE; DOWN REGULATION; GENETICS; HUMAN; LEUKEMIA; LYMPHOMA; MALE; METABOLISM; PHYSIOLOGY; TUMOR CELL LINE;

ANIMALS; APOPTOSIS; B-LYMPHOCYTES; CELL CYCLE; CELL LINE, TUMOR; CELL NUCLEUS; CELLULAR REPROGRAMMING TECHNIQUES; DOWN-REGULATION; HISTONE DEACETYLASES; HUMANS; LEUKEMIA; LYMPHOMA; MALE; MEF2 TRANSCRIPTION FACTORS; MICE; NUCLEAR RECEPTOR CO-REPRESSOR 2; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-MYC;

EID: 84927583783     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2014.594     Document Type: Article

References (39)

1. Adolfsson J, Mansson R, Buza-Vidas N, Hultquist A, Liuba K, Jensen CT et al. Identification of Flt3+ lympho-myeloid stem cells lacking erythro-megakaryocytic potential a revised road map for adult blood lineage commitment. Cell 2005; 121: 295-306.
2. Yoshida T, Ng SY, Zuniga-Pflucker JC, Georgopoulos K. Early hematopoietic lineage restrictions directed by Ikaros. Nat Immunol 2006; 7: 382-391.
3. Stehling-Sun S, Dade J, Nutt SL, DeKoter RP, Camargo FD. Regulation of lymphoid versus myeloid fate 'choice' by the transcription factor Mef2c. Nat Immunol 2009; 10: 289-296.
4. Bain G, Maandag EC, Izon DJ, Amsen D, Kruisbeek AM, Weintraub BC et al. E2A proteins are required for proper B cell development and initiation of immunoglobulin gene rearrangements. Cell 1994; 79: 885-892.
5. Bain G, Robanus Maandag EC, te Riele HP, Feeney AJ, Sheehy A, Schlissel M et al. Both E12 and E47 allow commitment to the B cell lineage. Immunity 1997; 6: 145-154.
6. Zhuang Y, Soriano P, Weintraub H. The helix-loop-helix gene E2A is required for B cell formation. Cell 1994; 79: 875-884.
7. Lin H, Grosschedl R. Failure of B-cell differentiation in mice lacking the transcription factor EBF. Nature 1995; 376: 263-267.
8. Dengler HS, Baracho GV, Omori SA, Bruckner S, Arden KC, Castrillon DH et al. Distinct functions for the transcription factor Foxo1 at various stages of B cell differentiation. Nat Immunol 2008; 9: 1388-1398.
9. Urbánek P, Wang ZQ, Fetka I, Wagner EF, Busslinger M. Complete block of early B cell differentiation and altered patterning of the posterior midbrain in mice lacking Pax5/BSAP. Cell 1994; 79: 901-912.
10. Kuiper RP, Schoenmakers EF, van Reijmersdal SV, Hehir-Kwa JY, van Kessel AG, van Leeuwen FN et al. High-resolution genomic profiling of childhood ALL reveals novel recurrent genetic lesions affecting pathways involved in lymphocyte differentiation and cell cycle progression. Leukemia 2007; 21: 1258-1266.
11. Mullighan CG. Genomic profiling of B-progenitor acute lymphoblastic leukemia. Best Pract Res Clin Haematol 2011; 24: 489-503.
12. Delgado MD, León J. Myc roles in hematopoiesis and leukemia. Genes Cancer 2010; 1: 605-616.
13. Tijchon E, Havinga J, van Leeuwen FN, Scheijen B. B-lineage transcription factors and cooperating gene lesions required for leukemia development. Leukemia 2013; 27: 541-552.
14. Delogu A, Schebesta A, Sun Q, Aschenbrenner K, Perlot T, Busslinger M. Gene repression by Pax5 in B cells is essential for blood cell homeostasis and is reversed in plasma cells. Immunity 2006; 24: 269-281.
15. Treiber T, Mandel EM, Pott S, Györy I, Firner S, Liu ET et al. Early B cell factor 1 regulates B cell gene networks by activation, repression, and transcription-independent poising of chromatin. Immunity 2010; 32: 714-725.
16. Martin M, Kettmann R, Dequiedt F. Class IIa histone deacetylases: conducting development and differentiation. Int J Dev Biol 2009; 53: 291-301.
17. Parra M, Verdin E. Regulatory signal transduction pathways for class IIa histone deacetylases. Curr Opin Pharmacol 2010; 10: 454-460.
18. Barneda-Zahonero B, Parra M. Histone deacetylases and cancer. Mol Oncol 2012; 6: 579-589.
19. Shi BW, Xu WF. The development and potential clinical utility of biomarkers for HDAC inhibitors. Drug Discov Ther 2013; 7: 129-136.
20. Barneda-Zahonero B, Román-González L, Collazo O, Rafati H, Islam AB, Bussmann LH et al. HDAC7 is a repressor of myeloid genes whose downregulation is required for transdifferentiation of pre-B cells into macrophages. PLoS Genet 2013; 9: e1003503.
21. Dequiedt F, Kasler H, Fischle W, Kiermer V, Weinstein M, Herndier BG et al. HDAC7, a thymus-specific class II histone deacetylase, regulates Nur77 transcription and TCRmediated apoptosis. Immunity 2003; 18: 687-698.
22. Kasler HG, Verdin E. Histone deacetylase 7 functions as a key regulator of genes involved in both positive and negative selection of thymocytes. Mol Cell Biol 2007; 27: 5184-5200.
23. Kasler HG, Young BD, Mottet D, Lim HW, Collins AM, Olson EN et al. Histone deacetylase 7 regulates cell survival and TCR signaling in CD4/CD8 double-positive thymocytes. J Immunol 2011; 186: 4782-4793.
24. Kasler HG, Lim HW, Mottet D, Collins AM, Lee IS, Verdin E. Nuclear export of histone deacetylase 7 during thymic selection is required for immune self-tolerance. EMBO J 2012; 31: 4453-4465.
25. Parra M, Kasler H, McKinsey TA, Olson EN, Verdin E. Protein kinase D1 phosphorylates HDAC7 and induces its nuclear export after T-cell receptor activation. J Biol Chem 2005; 280: 13762-13770.
26. Parra M, Mahmoudi T, Verdin E. Myosin phosphatase dephosphorylates HDAC7, controls its nucleocytoplasmic shuttling, and inhibits apoptosis in thymocytes. Genes Dev 2007; 21: 638-643.
27. Rad R, Rad L, Wang W, Cadinanos J, Vassiliou G, Rice S et al. PiggyBac transposon mutagenesis: a tool for cancer gene discovery in mice. Science 2010; 330: 1104-1107.
28. Khan O, La Thangue NB. HDAC inhibitors in cancer biology: emerging mechanisms and clinical applications. Immunol Cell Biol 2012; 90: 85-94.
29. Heideman MR, Wilting RH, Yanover E, Velds A, de Jong J, Kerkhoven RM et al. Dosage-dependent tumor suppression by histone deacetylases 1 and 2 through regulation of c-Myc collaborating genes and p53 function. Blood 2013; 121: 2038-2050.
30. Bhaskara S, Knutson SK, Jiang G, Chandrasekharan MB, Wilson AJ, Zheng S et al. Hdac3 is essential for the maintenance of chromatin structure and genome stability. Cancer Cell 2010; 18: 436-447.
31. Van Damme M, Crompot E, Meuleman N, Mineur P, Bron D, Lagneaux L et al. HDAC isoenzyme expression is deregulated in chronic lymphocytic leukemia B-cells and has a complex prognostic significance. Epigenetics 2012; 7: 1403-1412.
32. Yan-Fang T, Dong W, Li P, Wen-Li Z, Jun L, Na W et al. Analyzing the gene expression profile of pediatric acute myeloid leukemia with real-time PCR arrays. Cancer Cell Int 2012; 12: 40.
33. Wang JC, Kafeel MI, Avezbakiyev B, Chen C, Sun Y, Rathnasabapathy C et al. Histone deacetylase in chronic lymphocytic leukemia. Oncology 2011; 81: 325-329.
34. Moreno DA, Scrideli CA, Cortez MA, de Paula Queiroz R, Valera ET, da Silva Silveira V et al. Differential expression of HDAC3, HDAC7 and HDAC9 is associated with prognosis and survival in childhood acute lymphoblastic leukaemia. Br J Haematol 2010; 150: 665-673.
35. Geng H, Brennan S, Milne TA, Chen WY, Li Y, Hurtz C et al. Integrative epigenomic analysis identifies biomarkers and therapeutic targets in adult B-acute lymphoblastic leukemia. Cancer Discov 2012; 2: 1004-1023.
36. Sandhu SK, Volinia S, Costinean S, Galasso M, Neinast R, Santhanam R et al. miR-155 targets histone deacetylase 4 (HDAC4) and impairs transcriptional activity of B-cell lymphoma 6 (BCL6) in the Eμ-miR-155 transgenic mouse model. Proc Natl Acad Sci USA 2012; 109: 20047-20052.
37. Perez-Llamas C, Lopez-Bigas N. Gitools: analysis and visualisation of genomic data using interactive heat-maps. PLoS One 2011; 6: e19541.
38. Schones DE, Smith AD, Zhang MQ. Statistical significance of cis-regulatory modules. BMC Bioinformatics 2007; 8: 19.
39. Matys V, Kel-Margoulis OV, Fricke E, Liebich I, Land S, Barre-Dirrie A et al. TRANSFAC and its module TRANSCompel: transcriptional gene regulation in eukaryotes. Nucleic Acids Res 2006; 34 (Database issue) D108-D110.